Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds

  • Martinez-Peinado, Nieves|||0000-0001-7107-5374
  • Cortés Serra, Núria|||0000-0001-5396-3757
  • Sherman, Julian
  • Rodriguez, Ana|||0000-0002-0060-3405
  • Gascon, Joaquim|||0000-0002-5045-1585
  • Alberola, Jordi|||0000-0002-1033-6339
  • Pinazo, Maria-Jesus|||0000-0002-4237-1075
  • Rodriguez-Cortes, Alheli|||0000-0003-3617-0119
  • Alonso Padilla, Julio|||0000-0003-4466-7969
  • Martori Muntsant, Clara|||0000-0002-7872-918X
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and affects over 6 million people worldwide. Development of new drugs to treat this disease remains a priority since those currently available have variable efficacy and frequent adverse effects, especially during the long regimens required for treating the chronic stage of the disease. T. cruzi modulates the host cell-metabolism to accommodate the cell cytosol into a favorable growth environment and acquire nutrients for its multiplication. In this study we evaluated the specific anti-T. cruzi activity of nine bio-energetic modulator compounds. Notably, we identified that 17-DMAG, which targets the ATP-binding site of heat shock protein 90 (Hsp90), has a very high (sub-micromolar range) selective inhibition of the parasite growth. This inhibitory effect was also highly potent (IC50 = 0.27 μmol L-1) against the amastigote intracellular replicative stage of the parasite. Moreover, molecular docking results suggest that 17-DMAG may bind T. cruzi Hsp90 homologue Hsp83 with good affinity. Evaluation in a mouse model of chronic T. cruzi infection did not show parasite growth inhibition, highlighting the difficulties encountered when going from in vitro assays onto preclinical drug developmental stages.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Evaluation of the Performance of the Loopamp Detection Kit for the Diagnosis of Chagas Disease in an Area Where It Is Not Endemic, Spain

  • Flores-Chavez, Maria|||0000-0003-2597-3100
  • Abras, Alba|||0000-0003-2002-1186
  • Ballart, Cristina
  • Ibáñez Perez, Ismael
  • Perez-Gordillo, Pilar
  • Gállego Culleré, Montserrat|||0000-0002-8143-9773
  • Muñoz-Batet, Carmen|||0000-0002-4150-8834
  • Moure García, Zaira
  • Sulleiro, Elena|||0000-0002-9783-6060
  • Nieto, Javier
  • García Diez, Emilia
  • Cruz, Israel|||0000-0002-2200-2360
  • Picado, Albert
In Spain, PCR is the tool of choice for the diagnosis of congenital Chagas disease (CD) and serology for diagnosing chronic CD. A loop-mediated isothermal amplification test for DNA detection showed good analytical performance and ease of use. In Spain, PCR is the tool of choice for the diagnosis of congenital Chagas disease (CD) and serology for diagnosing chronic CD. A loop-mediated isothermal amplification test for DNA detection showed good analytical performance and ease of use. We aimed to evaluate the performance of the Loopamp detection kit (Eiken Chemical Co. Ltd., Japan) (Tcruzi -LAMP) for congenital and chronic CD diagnosis using well-characterized samples. We included samples from 39 congenital and 174 chronic CD cases and from 48 uninfected children born to infected mothers and 34 nonchagasic individuals. The sensitivity, specificity, and accuracy of Tcruzi -LAMP were estimated using standard case definitions for congenital CD (positive result by parasitological or PCR tests or serology after 9 months of age) and chronic CD (positive serology by at least two tests). The Tcruzi -LAMP results were read by visual examination and a real-time fluorimeter. For congenital CD, Tcruzi -LAMP sensitivity was 97% for both types of reading; specificity was 92% by visual examination and 94% by fluorimeter. For chronic CD, sensitivity was 47% and specificity 100%. The accuracy in congenital CD was.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Parasitemia Levels in Trypanosoma cruzi Infection in Spain, an Area Where the Disease Is Not Endemic, Trends by Different Molecular Approaches

  • Flores-Chavez, Maria|||0000-0003-2597-3100
  • Abras, Alba|||0000-0003-2002-1186
  • Ballart, Cristina
  • Ibáñez-Perez, Ismael
  • Perez-Gordillo, Pilar
  • Gállego Culleré, Montserrat|||0000-0002-8143-9773
  • Muñoz-Batet, Carmen|||0000-0002-4150-8834
  • Moure García, Zaira
  • Sulleiro, Elena|||0000-0002-9783-6060
  • Nieto, Javier
  • García Diez, Emilia
  • Simón, Lorena
  • Cruz, Israel|||0000-0002-2200-2360
  • Picado, Alberto
Trypanosoma cruzi infection has expanded globally through human migration. In Spain, the mother-to-child route is the mode of transmission contributing to autochthonous Chagas disease (CD); however, most people acquired the infection in their country of origin and were diagnosed in the chronic phase (imported chronic CD). In this context, we assessed the quantitative potential of the Loopamp Trypanosoma cruzi detection kit (Sat- TcLAMP) based on satellite DNA (Sat-DNA) to determine parasitemia levels compared to those detected by real-time quantitative PCRs (qPCRs) targeting Sat-DNA (Sat-qPCR) and kinetoplast DNA minicircles (kDNA-qPCR). This study included 173 specimens from 39 autochthonous congenital and 116 imported chronic CD cases diagnosed in Spain. kDNAqPCR showed higher sensitivity than Sat-qPCR and Sat-TcLAMP. According to all quantitative approaches, parasitemia levels were significantly higher in congenital infection than in chronic CD (1 × 10-1 to 5 × 105 versus.1 × 10-1 to 6 × 103 parasite equivalents/mL, respectively [P < 0.001]). Sat-TcLAMP, Sat-qPCR, and kDNA-qPCR results were equivalent at high levels of parasitemia (P = 0.381). Discrepancies were significant for low levels of parasitemia and older individuals. Differences between Sat-TcLAMP and Sat-qPCR were not qualitatively significant, but estimations of parasitemia using Sat-TcLAMP were closer to those by kDNA-qPCR. Parasitemia changes were assessed in 6 individual cases in follow- up, in which trends showed similar patterns by all quantitative approaches. At high levels of parasitemia, Sat-TcLAMP, Sat-qPCR, and kDNA-qPCR worked similarly, but significant differences were found for the low levels characteristic of late chronic CD. A suitable harmonization strategy needs to be developed for low-level parasitemia detection using Sat-DNA- and kDNA-based tests.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Autochthonous and imported tegumentary leishmaniasis in Catalonia (Spain), Aetiological evolution in the last four decades and usefulness of different typing approaches based on biochemical, molecular and proteomic markers

  • Fernández-Arévalo, Anna|||0000-0003-4925-7184
  • Ballart, Cristina
  • Muñoz-Basagoiti, Jordana|||0000-0002-0384-5928
  • Basarte, Leire
  • Lobato, Gonzalo
  • Arnau Vila, Albert|||0000-0002-2339-5987
  • Abras, Alba|||0000-0003-2002-1186
  • Tebar, Silvia
  • Llovet Pellejero, Maria Teresa|||0000-0001-5746-0348
  • Lami, Patrick
  • Pratlong, Francine
  • Alsina, Mercè
  • Roé Crespo, Esther|||0000-0003-1601-9227
  • Puig Sanz, Lluís|||0000-0001-6083-0952
  • Muñoz-Batet, Carmen|||0000-0002-4150-8834
  • Gállego Culleré, Montserrat|||0000-0002-8143-9773
Leishmaniasis is a transmissible disease caused by Leishmania protozoa. Spain is endemic for both visceral and cutaneous leishmaniasis, the autochthonous aetiological agent being Leishmania infantum. Around the world, the L. donovani complex is associated with visceral symptoms, while any species of the Leishmania or Viannia subgenera affecting human can produce tegumentary forms. In a context of growing numbers of imported cases, associated with globalisation, the aim of this study was to analyse the aetiological evolution of human tegumentary leishmaniasis in a region of Spain (Catalonia). Fifty-six Leishmania strains, isolated from 1981 to 2018, were analysed using MLEE, gene sequencing (hsp70, rpoIILS, fh and ITS2) and MALDI-TOF. The utility of these different analytical methods was compared. The results showed an increase in leishmaniasis over the two last decades, particularly imported cases, which represented 39% of all cases studied. Leishmania infantum, L. major, L. tropica, L. braziliensis, L. guyanensis and L. panamensis were identified. The combination of molecular and enzymatic methods allowed the identification of 29 different strain types (A to AC). Strain diversity was higher in L. (Viannia), whilst the different L. major types were relatable with geo-temporal data. Among the autochthonous cases, type C prevailed throughout the studied period (39%). Minor types generally appeared within a short time interval. While all the techniques provided identical identification at the species complex level, MALDI-TOF and rpoIILS or fh sequencing would be the most suitable identification tools for clinical practice, and the tandem hsp70-ITS2 could substitute MLEE in the epidemiological field.